Jiangxi Synergy Pharmaceutical (300636.SZ) passes the pharmaceutical GMP compliance inspection.

12/11/2024

GMT Eight

Jiangxi Synergy Pharmaceutical (300636.SZ) announced that it has recently received a notification from the Jiangxi Provincial Drug Administration that the company's active pharmaceutical ingredient Keligboroh has passed the drug GMP compliance inspection through on-site inspection and comprehensive evaluation.

In September, Hong Kong's overall export volume and import volume increased by 1.2% and decreased by 1.2% year-on-year, respectively.

Fangzheng Securities: Maintains a "strong recommendation" rating for SINO BIOPHARM (01177), and Anfangning has been approved for listing by the National Medical Products Administration.

Contact: contact@gmteight.com

Jiangxi Synergy Pharmaceutical (300636.SZ) passes the pharmaceutical GMP compliance inspection.

RECOMMEND

LFG INV HLDGS (03938) issues a profit warning, expecting a shareholder's share of net loss of no less than HK$16 million in the medium term.

DING YI FENG (00612) has a comprehensive net asset value of approximately HK$0.37 per share at the end of October.

Shenwan Hongyuan Group (00218.HK): Independent non-executive director Wu Yongkang passes away